deepeye Medical

📍 Munich, Germany🗓 Founded 2021👥 21 employees💰 Last funded Aug 2023
100+ million people globally suffer from vision-threatening retinal diseases. A $13bn drug can stop patients from vision loss. Still, ⅔ of cases of blindness in EU+US are due to these diseases like wet AMD. We provide an AI-based precision health platform that emulates a proven clinical method. This method used 2nd expert opinion for eye doctors to achieve 6x(!) better therapy results across thousands of patients: - Improving real-world vision outcomes by 3x (36% > 100%) - Keeping 2x more patients in therapy (38% > 78%) Our big vision is to prevent 1 million additional people from blindness by 2030 by empowering ophthalmologists with AI-based optimal therapy prognosis. Our pre-clinical AI is used by pharma, payors and providers’ associations to gain new insights on their therapy data. We work on our clinical product to provide therapy decision support with 1 click at the PoC in 2024.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
Germany
3
Investor activity2022–2023 · investors recorded per year
2022120232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in deepeye Medical?
deepeye Medical has 3 investors on record on gritt.io, including 3 early-stage backers.
When did deepeye Medical last raise funding?
The most recent investment in deepeye Medical recorded on gritt.io was in August 2023.
When was deepeye Medical founded?
deepeye Medical was founded in 2021.
What industry is deepeye Medical in?
deepeye Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is deepeye Medical based?
deepeye Medical is headquartered in Munich, Germany.